Publishing research using ab8940? Please let us know so that we can cite the reference in this datasheet.

ab8940 has been referenced in 7 publications.

  • Cotugno G  et al. Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction. PLoS One 7:e33286 (2012). IHC-FoFr ; Rat . PubMed: 22428010
  • Li G  et al. Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. Mol Vis 17:3156-65 (2011). IHC-Fr ; Mouse . PubMed: 22171162
  • Lobbes MB  et al. Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-of-concept study. Invest Radiol 45:275-81 (2010). IHC-P ; Human . PubMed: 20351652
  • Conde-Vancells J  et al. Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl 4:416-425 (2010). WB ; Rat . PubMed: 20535238
  • Argaw AT  et al. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 106:1977-1982 (2009). IHC-FoFr ; Mouse . PubMed: 19174516
  • Lobbes MB  et al. Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model--comparison of gadofosveset and gadopentetate dimeglumine. Radiology 250:682-91 (2009). PubMed: 19244042
  • Brantley JG  et al. Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis. Kidney Int 63:1240-8 (2003). PubMed: 12631340

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"